Atizoram

Atizoram

SCHEMBL5083334

COc1ccc(C2CNC(=O)NC2)cc1O[C@H]1C[C@@H]2CCC1C2

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 13/20 0.53
PDE4B Q07343 12/20 0.53
PDE4C Q08493 11/20 0.53
PDE4D Q08499 11/20 0.53
CYP3A4 P08684 2/20 0.50
VEGFA P15692 1/20 0.50
ALDH1A1 P00352 1/20 0.50
LMNA P02545 1/20 0.50
CYP1A2 P05177 1/20 0.50
MAPT P10636 1/20 0.50
CYP2C9 P11712 1/20 0.50
ALOX15 P16050 1/20 0.50
CREBBP Q92793 1/20 0.50
KDM4E B2RXH2 1/20 0.50
PDE5A O76074 1/20 0.50
TNF P01375 1/20 0.50
MAPK1 P28482 1/20 0.50
BLM P54132 1/20 0.50
PDE1A P54750 1/20 0.50
PDE1B Q01064 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Atizoram SCHEMBL14418236 1.00 PDE4A (0.53) PDE4APDE4BPDE4CPDE4DCYP3A4
Atizoram SCHEMBL7270902 1.00 PDE4A (0.53) PDE4APDE4BPDE4CPDE4DCYP3A4
Atizoram SCHEMBL450389 1.00 PDE4A (0.53) PDE4APDE4BPDE4CPDE4DCYP3A4
Atizoram SCHEMBL13016486 1.00 PDE4A (0.53) PDE4APDE4BPDE4CPDE4DCYP3A4
Atizoram SCHEMBL14473158 1.00 PDE4A (0.53) PDE4APDE4BPDE4CPDE4DCYP3A4
Atizoram SCHEMBL5963836 1.00 PDE4A (0.53) PDE4APDE4BPDE4CPDE4DCYP3A4
Atizoram SCHEMBL450388 1.00 PDE4A (0.53) PDE4APDE4BPDE4CPDE4DCYP3A4
Atizoram SCHEMBL7270904 1.00 PDE4A (0.53) PDE4APDE4BPDE4CPDE4DCYP3A4
Atizoram SCHEMBL20883039 1.00 PDE4A (0.53) PDE4APDE4BPDE4CPDE4DCYP3A4
Atizoram SCHEMBL3416683 1.00 PDE4A (0.53) PDE4APDE4BPDE4CPDE4DCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8242146-B2 Administering ROFLUMILAS and DICLOFENAC; antiinflammatory agents NYCOMED GMBH (DE) 2012-08-14 US disclosed
US-20080255209-A1 Combination of a NSAID and a PDE-4 inhibitor NYCOMED GMBH (DE) 2008-10-16 US disclosed